Microbiology

  1. Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2

    1. Anvita Bhargava
    2. Ugo Szachnowski
    3. Maxime Chazal
    4. Dominika Foretek
    5. Vincent Caval
    6. Sophie-Marie Aicher
    7. Juliana Pipoli da Fonseca
    8. Patricia Jeannin
    9. Guillaume Beauclair
    10. Marc Monot
    11. Antonin Morillon
    12. Nolwenn Jouvenet

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution

    1. Tyler N. Starr
    2. Allison J. Greaney
    3. William W. Hannon
    4. Andrea N. Loes
    5. Kevin Hauser
    6. Josh R. Dillen
    7. Elena Ferri
    8. Ariana Ghez Farrell
    9. Bernadeta Dadonaite
    10. Matthew McCallum
    11. Kenneth A. Matreyek
    12. Davide Corti
    13. David Veesler
    14. Gyorgy Snell
    15. Jesse D. Bloom

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2

    1. Hirofumi Ohashi
    2. Takayuki Hishiki
    3. Daisuke Akazawa
    4. Kwang Su Kim
    5. Joohyeon Woo
    6. Kaho Shionoya
    7. Kana Tsuchimoto
    8. Shoya Iwanami
    9. Saya Moriyama
    10. Hitomi Kinoshita
    11. Souichi Yamada
    12. Yudai Kuroda
    13. Tsukasa Yamamoto
    14. Noriko Kishida
    15. Shinji Watanabe
    16. Hideki Hasegawa
    17. Hideki Ebihara
    18. Tadaki Suzuki
    19. Ken Maeda
    20. Shuetsu Fukushi
    21. Yoshimasa Takahashi
    22. Shingo Iwami
    23. Koichi Watashi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Mitoquinone mesylate targets SARS-CoV-2 infection in preclinical models

    1. Anton Petcherski
    2. Madhav Sharma
    3. Sandro Satta
    4. Maria Daskou
    5. Hariclea Vasilopoulos
    6. Cristelle Hugo
    7. Eleni Ritou
    8. Barbara Jane Dillon
    9. Eileen Fung
    10. Gustavo Garcia
    11. Claudio Scafoglio
    12. Arunima Purkayastha
    13. Brigitte N Gomperts
    14. Gregory A Fishbein
    15. Vaithilingaraja Arumugaswami
    16. Marc Liesa
    17. Orian S Shirihai
    18. Theodoros Kelesidis

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Omicron BA.1 and BA.2 are antigenically distinct SARS-CoV-2 variants

    1. Anna Z. Mykytyn
    2. Melanie Rissmann
    3. Adinda Kok
    4. Miruna E. Rosu
    5. Debby Schipper
    6. Tim I. Breugem
    7. Petra B. van den Doel
    8. Felicity Chandler
    9. Theo Bestebroer
    10. Maurice de Wit
    11. Martin E. van Royen
    12. Richard Molenkamp
    13. Bas B. Oude Munnink
    14. Rory D. de Vries
    15. Corine GeurtsvanKessel
    16. Derek J. Smith
    17. Marion P. G. Koopmans
    18. Barry Rockx
    19. Mart M. Lamers
    20. Ron Fouchier
    21. Bart L. Haagmans

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Bacterial metatranscriptomes in wastewater can differentiate virally infected human populations

    1. Rodolfo A Salido
    2. Cameron Martino
    3. Smruthi Karthikeyan
    4. Shi Huang
    5. Gibraan Rahman
    6. Antonio Gonzalez
    7. Livia S. Zaramela
    8. Kristen L Beck
    9. Shrikant Bhute
    10. Kalen Cantrell
    11. Anna Paola Carrieri
    12. Sawyer Farmer
    13. Niina Haiminen
    14. Greg Humphrey
    15. Ho-Cheol Kim
    16. Laxmi Parida
    17. Alex Richter
    18. Yoshiki Vázquez-Baeza
    19. Karsten Zengler
    20. Austin D. Swafford
    21. Andrew Bartko
    22. Rob Knight

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Potent Neutralizing Activity of Polyclonal Equine Antibodies against Omicron SARS-CoV-2

    1. J. Luczkowiak
    2. P. Radreau
    3. L. Nguyen
    4. N. Labiod
    5. F. Lasala
    6. C.H. Herbreteau
    7. R. Delgado

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model

    1. Caroline S. Foo
    2. Rana Abdelnabi
    3. Laura Vangeel
    4. Steven De Jonghe
    5. Dirk Jochmans
    6. Birgit Weynand
    7. Johan Neyts

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model

    1. Kyle Rosenke
    2. Atsushi Okumura
    3. Matthew C. Lewis
    4. Friederike Feldmann
    5. Kimberly Meade-White
    6. W. Forrest Bohler
    7. Amanda Griffin
    8. Rebecca Rosenke
    9. Carl Shaia
    10. Michael A. Jarvis
    11. Heinz Feldmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulation

    1. Shiho Torii
    2. Kwang Su Kim
    3. Jun Koseki
    4. Rigel Suzuki
    5. Shoya Iwanami
    6. Yasuhisa Fujita
    7. Yong Dam Jeong
    8. Yoshiharu Matsuura
    9. Teppei Shimamura
    10. Shingo Iwami
    11. Takasuke Fukuhara

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 110 of 252 Next